Cameco Corporation (USA)  

(Public, NYSE:CCJ)   Watch this stock  
Find more results for ccj
21.58
+0.33 (1.55%)
Real-time:   3:02PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 21.25 - 21.73
52 week 16.41 - 23.23
Open 21.28
Vol / Avg. 669,749.00/1.66M
Mkt cap 8.53B
P/E 60.98
Div/yield 0.10/1.84
EPS 0.35
Shares 395.40M
Beta 1.54
Inst. own 74%
Jul 26, 2013
Q2 2013 Cameco Earnings Release Add to calendar
May 14, 2013
Cameco Annual Shareholder Meeting
May 1, 2013
Q1 2013 Cameco Earnings Conference Call
May 1, 2013
Q1 2013 Cameco Earnings Release
Feb 26, 2013
Cameco at BMO Global Metals & Mining Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 1.88% 11.40%
Operating margin 3.87% 11.60%
EBITD margin - 31.54%
Return on average assets 0.45% 3.34%
Return on average equity 0.69% 5.40%
Employees 3,470 -
Carbon Disclosure Rating - 63/100

Address

2121-11th Street West
SASKATOON, SK S7M 1J3
Canada
+1-306-9566200 (Phone)
+1-306-9566201 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha
Discussion Group - Google Finance

Description

Cameco Corporation (Cameco) is engaged in the exploration for and the development, mining, refining, conversion and fabrication of uranium for sale as fuel for generating electricity in nuclear power reactors in Canada and other countries. Cameco has a 31.6% interest in Bruce Power L.P. (BPLP), which operates the four Bruce B nuclear reactors in Ontario. Cameco has three reportable segments: uranium, fuel services and electricity. In January 2013, the Company acquired NUKEM Energy GmbH.

Officers and directors

Timothy S. Gitzel President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Grant E. Isaac Chief Financial Officer, Senior Vice President
Bio & Compensation  - Reuters
Robert A. Steane Chief Operating Officer, Senior Vice President
Bio & Compensation  - Reuters
Kenneth A. Seitz Senior Vice President, Chief Compliance Officer
Bio & Compensation  - Reuters
Gary M. S. Chad QC Senior Vice President, Chief Legal Officer and Corporate Secretary
Bio & Compensation  - Reuters
Donald H. F. Deranger Director
Age: 57
Bio & Compensation  - Reuters
Ian D. Bruce Independent Director
Age: 59
Bio & Compensation  - Reuters
Daniel Camus Independent Director
Age: 61
Bio & Compensation  - Reuters
John Henry Clappison Independent Director
Age: 66
Bio & Compensation  - Reuters
Joe F. Colvin Independent Director
Age: 70
Bio & Compensation  - Reuters